Avian Influenza Vaccines Market: Global Market Estimation, Dynamics, Trends, Competitor Analysis 2016-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Global Avian Influenza Vaccines Market: By Strain Type (Type H9, Type H7, Type H5 and Others), By Vaccine Type (Live Recombinant Vaccines, Inactivated Vaccines and Combination Vaccines), By Application Type (Duck & Goose, Chicken and Others), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The Avian Influenza Vaccine Market size is estimated to be valued at USD 140.0 million in 2021 and is poised to grow at a CAGR of 4.2% over 2022-2028. Avian influenza, commonly known as bird flu, is a viral virus that transmits from birds to other animals including people. There are other forms of avian influenza that cause infection, but H5V1 is the most frequent viral strain that affects poultry.  Based on strain type, the global avian influenza vaccine market is segmented into type H9, type H7, type H5, and Others. H5 is the most common virus strain segment and holds most of the market share in the global influenza vaccine market. The majority of A(H5) viruses seen in wild birds and poultry are LPAI, however, HPAI A(H5) viruses have also been found. Human infections with A(H5) viruses have been reported sporadically, such as with HPAI A(H5N1) viruses linked to poultry epidemics in various countries across the globe. For instance, in March 2022, highly pathogenic avian influenza A(H5N1) viruses (“H5N1 bird flu viruses”) have been detected in USA wild birds in 14 states. Increasing government initiatives to raise awareness about avian influenza among the farmers, rise in private-sector financing for the development of effective avian influenza vaccines, and increased poultry bird production are expected to contribute to the market growth.

Recent Market Developments:

In October 2019, Ceva and ProBioGen AG signed an exclusive license agreement for the manufacture of vectorized poultry vaccines using ProBioGen’s proprietary AGE1.CR technology.

In October 2018, Boehringer Ingelheim announced the opening of its biological research and development site in France. It invested USD 80.45 million (EUR 70 million) for maintaining its leading position in veterinary vaccines.

Avian Influenza Vaccines Market

MARKET SUMMARY
-
4.2% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 4.2%
  • Largest Market– Asia-Pacific
  • Fastest Growing Market– North-America

Avian Influenza Vaccines Market

  • The report on global avian influenza vaccines market gives historical, current and future market sizes (US$ Mn) based on strain type, vaccine type, application type and region.
  • avian influenza vaccines market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • Key stakeholders of the global avian influenza vaccines market report include suppliers, manufacturers, marketers, policy makers, and service providers engaged in global avian influenza vaccines products.
Key Players
  • CEVA
  • FATRO
  • Biken
  • HVRI
  • Merial
Avian Influenza Vaccines Market

Dynamics

The industry is likely to offer significant opportunities as a result of an increase in public and private initiatives by the government and non-government organizations for research and development activities. For instance, In February 2018, the NC State College of Veterinary Medicine and Ceva Santé Animale, a French animal health organization, engaged on a distance learning project to provide certification in poultry health management to veterinarians in Latin America.


North-America got significant share

Avian Influenza Vaccines Market

North America is anticipated to account for the largest market share during the forecast period, owing to ongoing research and development activities and growing awareness among livestock farmers about the vaccination in the region. Europe is projected to account for the second-largest share of the global market, in terms of revenue. Furthermore, the avian influenza vaccine market in the Asia Pacific is expected to grow at a rapid rate due to developing economies like India and China making major contributions. The avian influenza vaccine market in Asia Pacific is driven by a growing reliance on chicken as a primary source of protein in the diet and a rising prevalence of avian influenza disease in the region.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The Avian Influenza Vaccine market report provides granular level information about the market size, regional market share, historic market (2016-2021) and forecast (2022-2028)
  • The Avian Influenza Vaccine market report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The Avian Influenza Vaccine market report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The Avian Influenza Vaccine market report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The Avian Influenza Vaccine market report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Avian Influenza Vaccines Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

1. Executive Summary
2. Global Avian Influenza Vaccines Market Introduction
2.1. Global Avian Influenza Vaccines Market – Taxonomy
2.2. Global Avian Influenza Vaccines Market –Definitions
2.2.1. Strain
2.2.2. Vaccine Type
2.2.3. Application
3. Global Avian Influenza Vaccines Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Avian Influenza Vaccines Market Dynamic Factors – Impact Analysis
3.6. Global Avian Influenza Vaccines Market – Competition Landscape
4. Global Avian Influenza Vaccines Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025
4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Avian Influenza Vaccines Market, By Strain, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
5.1. Type H9
5.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Type H7
5.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Type H5
5.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Others
5.4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
6. Global Avian Influenza Vaccines Market Forecast, By Vaccine Type, 2014 – 2018 and Forecast, 2019 – 2025
6.1. Live Recombinant Vaccines
6.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Inactivated Vaccines
6.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Combination Vaccines
6.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global Avian Influenza Vaccines Market Forecast, By Application, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
7.1. Duck & Goose
7.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Chicken
7.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Other Application
7.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global Avian Influenza Vaccines Market Forecast, By Region, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Avian Influenza Vaccines Market – Opportunity Analysis Index, By Strain, Vaccine Type, Application, and Region, 2019 – 2025
9. North America Avian Influenza Vaccines Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
9.1. Strain Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Type H9
9.1.2. Type H7
9.1.3. Type H5
9.1.4. Others
9.2. Vaccine Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Live Recombinant Vaccines
9.2.2. Inactivated Vaccines
9.2.3. Combination Vaccines
9.3. Application Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Duck & Goose
9.3.2. Chicken
9.3.3. Other Application
9.4. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. U.S.
9.4.2. Canada
9.5. North America Avian Influenza Vaccines Market – Opportunity Analysis Index, By Strain, Vaccine Type, Application, and Country, 2019 – 2025
9.6. North America Avian Influenza Vaccines Market Dynamics – Trends
10. Europe Avian Influenza Vaccines Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
10.1. Strain Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Type H9
10.1.2. Type H7
10.1.3. Type H5
10.1.4. Others
10.2. Vaccine Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Live Recombinant Vaccines
10.2.2. Inactivated Vaccines
10.2.3. Combination Vaccines
10.3. Application Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Duck & Goose
10.3.2. Chicken
10.3.3. Other Application
10.4. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Poland
10.4.8. Rest of Europe
10.5. Europe Avian Influenza Vaccines Market – Opportunity Analysis Index, By Strain, Vaccine Type, Application, and Country, 2019 – 2025
10.6. Europe Avian Influenza Vaccines Market Dynamics – Trends
11. Asia-Pacific Avian Influenza Vaccines Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
11.1. Strain Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Type H9
11.1.2. Type H7
11.1.3. Type H5
11.1.4. Others
11.2. Vaccine Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Live Recombinant Vaccines
11.2.2. Inactivated Vaccines
11.2.3. Combination Vaccines
11.3. Application Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Duck & Goose
11.3.2. Chicken
11.3.3. Other Application
11.4. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Avian Influenza Vaccines Market – Opportunity Analysis Index, By Strain, Vaccine Type, Application, and Country, 2019 – 2025
11.6. Asia-Pacific Avian Influenza Vaccines Market Dynamics – Trends
12. Latin America Avian Influenza Vaccines Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
12.1. Strain Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Type H9
12.1.2. Type H7
12.1.3. Type H5
12.1.4. Others
12.2. Vaccine Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Live Recombinant Vaccines
12.2.2. Inactivated Vaccines
12.2.3. Combination Vaccines
12.3. Application Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Duck & Goose
12.3.2. Chicken
12.3.3. Other Application
12.4. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Venezuela
12.4.5. Rest of Latin America
12.5. Latin America Avian Influenza Vaccines Market – Opportunity Analysis Index, By Strain, Vaccine Type, Application, and Country, 2019 – 2025
12.6. Latin America Avian Influenza Vaccines Market Dynamics – Trends
13. Middle East and Africa Avian Influenza Vaccines Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)
13.1. Strain Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Type H9
13.1.2. Type H7
13.1.3. Type H5
13.1.4. Others
13.2. Vaccine Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Live Recombinant Vaccines
13.2.2. Inactivated Vaccines
13.2.3. Combination Vaccines
13.3. Application Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Duck & Goose
13.3.2. Chicken
13.3.3. Other Application
13.4. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Avian Influenza Vaccines Market – Opportunity Analysis Index, By Strain, Vaccine Type, Application, and Country, 2019 – 2025
13.6. MEA Avian Influenza Vaccines Market Dynamics – Trends
14. Competition Landscape
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.2. CEVA
14.2.3. FATRO
14.2.4. Kyoto Biken
14.2.5. Merial
14.2.6. QYH Biotech
14.2.7. Merck
14.2.8. Zoetis
14.2.9. Elanco
14.2.10. Avimex Laboratories
14.2.11. HVRI
15. Research Methodology
16. Key Assumptions and Acronyms


Report

Company Profile

  • CEVA
  • FATRO
  • Biken
  • HVRI
  • Merial
  • Merial
  • Merck
  • Zoetis
  • Elanco
  • Avimex Laboratories

Report

List of Tables and Figures

List of Tables:

Table 01: Global Avian Influenza Vaccines Market – Historical, Forecast Market Sizes (US$ Mn), by Strain Type, 2014-2025

Table 02: Global Avian Influenza Vaccines Market – Historical, Forecast Market Sizes (US$ Mn), by Application Type, 2014-2025

Table 03: Global Avian Influenza Vaccines Market – Historical, Forecast Market Sizes (US$ Mn), by Vaccine Type, 2014-2025

Table 04: Global Avian Influenza Vaccines Market – Historical, Forecast Market Sizes (US$ Mn), By Region, 2014-2025

Table 05: North America Avian Influenza Vaccines Market- Historical, Forecast Market Sizes (US$ Mn), By Country, 2014-2025

Table 06: North America Avian Influenza Vaccines Market – Historical, Forecast Market Sizes (US$ Mn), by Strain Type, 2014-2025

Table 07: North America Avian Influenza Vaccines Market – Historical, Forecast Market Sizes (US$ Mn), by Application Type, 2014-2025

Table 08: North America Avian Influenza Vaccines Market – Historical, Forecast Market Sizes (US$ Mn), by Vaccine Type, 2014-2025

Table 09: Europe Avian Influenza Vaccines Market- Historical, Forecast Market Sizes (US$ Mn), By Country, 2014-2025

Table 10: Europe Avian Influenza Vaccines Market – Historical, Forecast Market Sizes (US$ Mn), by Strain Type, 2014-2025

Table 11: Europe Avian Influenza Vaccines Market – Historical, Forecast Market Sizes (US$ Mn), by Vaccine Type, 2014-2025

Table 12: Europe Avian Influenza Vaccines Market – Historical, Forecast Market Sizes (US$ Mn), by Application Type, 2014-2025

Table 13: Asia Pacific Avian Influenza Vaccines Market- Historical, Forecast Market Sizes (US$ Mn), By Country, 2014-2025

Table 14: Asia Pacific Avian Influenza Vaccines Market – Historical, Forecast Market Sizes (US$ Mn), by Strain Type, 2014-2025

Table 15: Asia Pacific Avian Influenza Vaccines Market – Historical, Forecast Market Sizes (US$ Mn), by Vaccine Type, 2014-2025

Table 16: Asia Pacific Avian Influenza Vaccines Market – Historical, Forecast Market Sizes (US$ Mn), by Application Type, 2014-2025

Table 17: Latin America Avian Influenza Vaccines Market- Historical, Forecast Market Sizes (US$ Mn), By Country, 2014-2025

Table 18: Latin America Avian Influenza Vaccines Market – Historical, Forecast Market Sizes (US$ Mn), by Strain Type, 2014-2025

Table 19: Latin America Avian Influenza Vaccines Market – Historical, Forecast Market Sizes (US$ Mn), by Vaccine Type, 2014-2025

Table 20: Latin America Avian Influenza Vaccines Market – Historical, Forecast Market Sizes (US$ Mn), by Application Type, 2014-2025

Table 21: MEA Avian Influenza Vaccines Market – Historical, Forecast Market Sizes (US$ Mn), by Country Type, 2014-2025

Table 22: MEA Avian Influenza Vaccines Market – Historical, Forecast Market Sizes (US$ Mn), by Strain Type, 2014-2025

Table 23: MEA Avian Influenza Vaccines Market – Historical, Forecast Market Sizes (US$ Mn), by Vaccine Type, 2014-2025

Table 24: MEA Avian Influenza Vaccines Market – Historical, Forecast Market Sizes (US$ Mn), by Application Type, 2014-2025

List of Figures:

Figure 01: Global Avian Influenza Vaccines Market Revenue Share (%), by Strain Type (2019)

Figure 02: Global Avian Influenza Vaccines Market Revenue Share ($ Mn), by Application Type (2019)

Figure 03: Global Avian Influenza Vaccines Market Revenue Share (%), by Vaccine Type (2019)

Figure 04: Global Avian Influenza Vaccines Market Revenue Share ($ Mn), by Region Type (2019)

Figure 05: Global Avian Influenza Vaccines Market- Regional Revenue Hotspots (2019)

Figure 06: Global Avian Influenza Vaccines Market- Historical, Forecast Market Sizes (US$ Mn), Volume and Y-o-Y Growth (%), 2014-2025

Figure 07: Global Avian Influenza Vaccines Market– Market Opportunity (US$ Mn)2014, 2018, & 2025

Figure 08: Global Avian Influenza Vaccines Market Share (%), by Strain Type, 2019 & 2025

Figure 09: Global Avian Influenza Vaccines Market Y-o-Y Growth (%), by Strain Type, 2019-2025

Figure 10: Type H9- Historical, Forecast Market Sizes (US$ Mn), Market Opportunity (US$ Mn), 2014 – 2025

Figure 11: Type H7- Historical, Forecast Market Sizes (US$ Mn) Market Opportunity (US$ Mn), 2014 – 2025

Figure 12: Type H5- Historical, Forecast Market Sizes (US$ Mn), Market Opportunity (US$ Mn), 2014-2025

Figure 13: Others- Historical, Forecast Market Sizes (US$ Mn), Market Opportunity (US$ Mn), 2014-2025

Figure 14: Global Avian Influenza Vaccines Market Share (%), by Application Type, 2019 & 2025

Figure 15: Global Avian Influenza Vaccines Market Y-o-Y Growth (%), by Application Type, 2018-2024

Figure16: Duck and Goose- Historical, Forecast Market Sizes (US$ Mn), Market Opportunity (US$ Mn), 2014-2025

Figure 17: Chicken- Historical, Forecast Market Sizes (US$ Mn) Market Opportunity (US$ Mn), 2014-2025

Figure 18: Others- Historical, Forecast Market Sizes (US$ Mn), Market Opportunity (US$ Mn), 2014-2025

Figure 19: Global Avian Influenza Vaccines Market Share (%), by Vaccine Type, 2019 & 2025

Figure 20: Global Avian Influenza Vaccines Market Y-o-Y Growth (%), by Vaccine Type, 2018-2024

Figure 21: Live Recombinant Vaccine- Historical, Forecast Market Sizes (US$ Mn), Market Opportunity (US$ Mn), 2014-2025

Figure 22: Inactivated Vaccine- Historical, Forecast Market Sizes (US$ Mn) Market Opportunity (US$ Mn), 2014-2025

Figure 23: Combination Vaccine- Historical, Forecast Market Sizes (US$ Mn), Market Opportunity (US$ Mn), 2014-2025

Figure 24: Global Avian Influenza Vaccines Market Share (%), By Region, 2019 & 2025

Figure 25: Global Avian Influenza Vaccines Market Y-o-Y Growth (%), by Region, 2019-2025

Figure 26: North America Avian Influenza Vaccines Market- Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), 2014-2025

Figure 27: Europe Avian Influenza Vaccines Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), 2014-2025

Figure 28: Asia-Pacific Avian Influenza Vaccines Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), 2014-2025

Figure 29: LATAM Avian Influenza Vaccines Market- Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), 2014-2025

Figure 30: MEA Avian Influenza Vaccines Market – Historical, Forecast Market Sizes (US$ Mn) and Market Opportunity (US$ Mn), 2014-2025

Figure 31: Global Avian Influenza Vaccines Market – Opportunity Analysis, by Strain Type 2019 – 2024

Figure 32: Global Avian Influenza Vaccines Market – Opportunity Analysis, by Vaccine Type, 2018 – 2024

Figure 33: Global Avian Influenza Vaccines Market – Opportunity Analysis, by Application Type 2019 – 2024

Figure 34: Global Avian Influenza Vaccines Market – Opportunity Analysis, By Region Type, 2018 – 2024

Figure 35: North America Avian Influenza Vaccines Market- Historical, Forecast Market Sizes (US$ Mn) andY-o-Y Growth (%), 2014 – 2025

Figure 36: North America Avian Influenza Vaccines Market– Market Opportunity (US$ Mn), 2014, 2018, & 2025

Figure 37: North America Avian Influenza Vaccines Market Share Analysis (%), by Strain Type, 2019

Figure 38:North America Avian Influenza Vaccines Market Share Analysis (%), by Vaccine Type, 2019

Figure 39: North America Avian Influenza Vaccines Market Share Analysis (%), by Application Type, 2019

Figure 40:North America Avian Influenza Vaccines Market Share Analysis (%), by Country Type, 2019

Figure 41: North America Avian Influenza Vaccines Market – Opportunity Analysis, by Strain Type 2019 – 2024

Figure 42: North America Avian Influenza Vaccines Market – Opportunity Analysis, by Vaccine Type, 2018 – 2024

Figure 43: North America Avian Influenza Vaccines Market – Opportunity Analysis, by Application Type 2019 – 2024

Figure 44: North America Avian Influenza Vaccines Market – Opportunity Analysis, By Region Type, 2018 – 2024

Figure 45: Europe Avian Influenza Vaccines Market- Historical, Forecast Market Sizes (US$ Mn) andY-o-Y Growth (%), 2014-2025

Figure 46: Europe Avian Influenza Vaccines Market– Market Opportunity (US$ Mn), 2016, 2018, & 2024

Figure 47: Europe Avian Influenza Vaccines Market Share Analysis (%), by Strain Type, 2019

Figure 48: Europe Avian Influenza Vaccines Market Share Analysis (%), by Vaccine Type, 2019

Figure 49: Europe Avian Influenza Vaccines Market Share Analysis (%), by Application Type, 2019

Figure 50: Europe Avian Influenza Vaccines Market Share Analysis (%), Country, 2019

Figure 51: Europe Avian Influenza Vaccines Market – Opportunity Analysis, by Strain Type 2019 – 2024

Figure 52: Europe Avian Influenza Vaccines Market – Opportunity Analysis, by Vaccine Type, 2018 – 2024

Figure 53: Europe Avian Influenza Vaccines Market – Opportunity Analysis, by Application Type 2019 – 2024

Figure 54: EuropeAvian Influenza Vaccines Market – Opportunity Analysis, By Region Type, 2018 – 2024

Figure 55: Asia Pacific Avian Influenza Vaccines Market- Historical, Forecast Market Sizes (US$ Mn) andY-o-Y Growth (%), 2014-2025

Figure 56: Asia Pacific Avian Influenza Vaccines Market– Market Opportunity (US$ Mn), 2016, 2018, & 2024

Figure 57: Asia Pacific Avian Influenza Vaccines Market Share Analysis (%), by Strain Type, 2019

Figure 58: Asia Pacific Avian Influenza Vaccines Market Share Analysis (%), by Vaccine Type, 2019

Figure 59: Asia Pacific Avian Influenza Vaccines Market Share Analysis (%), by Application Type, 2019

Figure 60: Asia Pacific Avian Influenza Vaccines Market Share Analysis (%), Country, 2019

Figure 61: Asia Pacific Avian Influenza Vaccines Market – Opportunity Analysis, by Strain Type 2019 – 2024

Figure 62: Asia Pacific Avian Influenza Vaccines Market – Opportunity Analysis, by Vaccine Type, 2018 – 2024

Figure 63: Asia Pacific Avian Influenza Vaccines Market – Opportunity Analysis, by Application Type 2019 – 2024

Figure 64: Asia Pacific Avian Influenza Vaccines Market – Opportunity Analysis, By Region Type, 2018 – 2024

Figure 65: Latin America Avian Influenza Vaccines Market- Historical, Forecast Market Sizes (US$ Mn) andY-o-Y Growth (%), 2014-2025

Figure 66: Latin America Avian Influenza Vaccines Market– Market Opportunity (US$ Mn), 2016, 2018, & 2024

Figure 67: Latin America Avian Influenza Vaccines Market Share Analysis (%), by StrainType, 2019

Figure 68: Latin America Avian Influenza Vaccines Market Share Analysis (%), by Vaccine Type, 2019

Figure 69: Latin America Avian Influenza Vaccines Market Share Analysis (%), by Application Type, 2019

Figure 70: Latin America Avian Influenza Vaccines Market Share Analysis (%), Country, 2019

Figure 71: Latin America Avian Influenza Vaccines Market – Opportunity Analysis, by Strain Type 2019 – 2024

Figure 72: Latin America Avian Influenza Vaccines Market – Opportunity Analysis, by Vaccine Type, 2018 – 2024

Figure 73: Latin America Avian Influenza Vaccines Market – Opportunity Analysis, by Application Type 2019 – 2024

Figure 74: Latin AmericaAvian Influenza Vaccines Market – Opportunity Analysis, By Region Type, 2018 – 2024

Figure 75: MEA Avian Influenza Vaccines Market- Historical, Forecast Market Sizes (US$ Mn) andY-o-Y Growth (%), 2014-2025

Figure 76: MEA Avian Influenza Vaccines Market– Market Opportunity (US$ Mn), 2016, 2018, & 2024

Figure 77: MEA Avian Influenza Vaccines Market Share Analysis (%), by Strain Type, 2019

Figure 78: MEA Avian Influenza Vaccines Market Share Analysis (%), by Vaccine Type, 2019

Figure 79: MEA Avian Influenza Vaccines Market Share Analysis (%), by Application Type, 2019

Figure 80: MEA Avian Influenza Vaccines Market Share Analysis (%), Country, 2019

Figure 81: MEA Avian Influenza Vaccines Market – Opportunity Analysis, by Strain Type 2019 – 2024

Figure 82: MEA Avian Influenza Vaccines Market – Opportunity Analysis, by Vaccine Type, 2018 – 2024

Figure 83: MEA Avian Influenza Vaccines Market – Opportunity Analysis, by Application Type 2019 – 2024

Figure 84: MEAAvian Influenza Vaccines Market – Opportunity Analysis, By Region Type, 2018 – 2024

Description

The Avian Influenza Vaccine Market size is estimated to be valued at USD 140.0 million in 2021 and is poised to grow at a CAGR of 4.2% over 2022-2028. Avian influenza, commonly known as bird flu, is a viral virus that transmits from birds to other animals including people. There are other forms of avian influenza that cause infection, but H5V1 is the most frequent viral strain that affects poultry.  Based on strain type, the global avian influenza vaccine market is segmented into type H9, type H7, type H5, and Others. H5 is the most common virus strain segment and holds most of the market share in the global influenza vaccine market. The majority of A(H5) viruses seen in wild birds and poultry are LPAI, however, HPAI A(H5) viruses have also been found. Human infections with A(H5) viruses have been reported sporadically, such as with HPAI A(H5N1) viruses linked to poultry epidemics in various countries across the globe. For instance, in March 2022, highly pathogenic avian influenza A(H5N1) viruses (“H5N1 bird flu viruses”) have been detected in USA wild birds in 14 states. Increasing government initiatives to raise awareness about avian influenza among the farmers, rise in private-sector financing for the development of effective avian influenza vaccines, and increased poultry bird production are expected to contribute to the market growth.

Recent Market Developments:

In October 2019, Ceva and ProBioGen AG signed an exclusive license agreement for the manufacture of vectorized poultry vaccines using ProBioGen’s proprietary AGE1.CR technology.

In October 2018, Boehringer Ingelheim announced the opening of its biological research and development site in France. It invested USD 80.45 million (EUR 70 million) for maintaining its leading position in veterinary vaccines.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX